Clinical Trial Management - software & AI news

Daily news on software, AI, and companies shaping clinical trial management.

Showing 118 results
Press release cover image

Sep 16, 2026

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

Interim data show high adherence and usability for remote, multimodal brain monitoring in borderline personality disorder and therapy-resistant depression, and a two-minute digital cognitive task performing comparably to clinical benchmarks for Alzheimer's trial pre-enrichment.BELFAST, Northern Ireland, Sept. 16, 2026 /PRNewswire/ -- First Published: 16 September, 2026Cumulus Neuroscience presented three posters at the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn
A trophy and microphone representing clinical innovation and presentations.

Sep 16, 2026

Trialynx Wins DPHARM Idol Disrupt 2026

Trialynx has emerged as the winner of the DPHARM Idol Disrupt competition during the 2026 DPHARM event, which focuses on innovative solutions to enhance clinical research.This annual event, part of Forge’s Fierce Life Sciences, aims to spotlight groundbreaking ideas in the clinical development space. The competition featured six finalists, each given six minutes to present their solutions to a panel of judges from various sectors, including pharmaceutical companies, healthcare organizations, and
Press release cover image

Sep 16, 2026

PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor

Pharmaceutical R&D and Life Sciences Veterans Will Advise PhaseV as it Scales AI Platform to Bridge the Gap Between Clinical Development Strategy, Execution and Regulatory SubmissionBOSTON, Sept. 16, 2026 /PRNewswire/ -- PhaseV, a leader in machine learning for clinical development, today announced the appointment of Klaus Beck, MD, PhD, PhD, former Chief Medical Officer of Organon, and Avi Kulkarni, PhD, MBA, CEO of InoRx, to its Scientific Advisory Board.Dr. Beck and Dr. Kulkarni bring dec
Press release cover image

Sep 14, 2026

Endpoint Clinical Acquires Bluefin, a Provider of Clinical Supply Forecasting and Planning Technology

This acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic.RALEIGH, N.C. and BOSTON, Sept. 14, 2026 /PRNewswire/ -- Endpoint Clinical L.P., a global leader in randomization and trial supply management ("RTSM") solutions and a portfolio company of Arsenal Capital Partners, today announced it has acquired Bluefin, a Boston-based provider of clinical supply forecasting and planning technology.The acquisition expands Endpoint into clinical sup
Press release cover image

Sep 11, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System

HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical's headquarters in Boston ahead of deployment in HOPE's Florida clinicsThe Zeta TMS Robotic System's AI-driven software adjusts the TMS coil in real time with submillimeter precision, building on the Zeta TMS Navigation System HOPE implemented earlier this summerDeployment supports SPARC-TMS, NRx's trial
Press release cover image

Sep 10, 2026

ObvioHealth and SPRIM PRO Launch Integrated Digital Patient Monitoring and Clinical Support Solution for High-Risk Therapies

New strategic offering combines digital health technology with clinical operations and patient support to help pharmaceutical companies modernize patient monitoring for REMS programs and other therapies requiring enhanced clinical oversight.NEW YORK, Sept. 10, 2026 /PRNewswire/ -- The pharmaceutical industry is entering a new era of increasingly specialized therapies that require more intensive patient monitoring beyond the point of care. Specialty medicines have accounted for more than half of
Press release cover image

Sep 10, 2026

Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S.

Collaboration combines Massive Bio's AI-driven trial matching and concierge support with PrecisCa's oncology provider network to increase patient surfacing and trial enrollment nationwideBOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, Inc., a global leader in AI-driven precision oncology and clinical trial matching, and PrecisCa, an oncology practice support platform offering evidence-based treatment guidance, clinical trial matching, patient communications, and expert second opinions, today ann
Press release cover image

Sep 9, 2026

Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026

Trialbee continues to bring fresh innovation to clinical trials with its Honey Platform™, demonstrating how AI is reshaping patient recruitment – and where it goes from hereMALMO, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader reimagining clinical trials with AI, will present alongside Takeda at DPHARM 2026 taking place September 15–16 in Boston.During the event, Trialbee will unveil AI patient screening in its Honey Platform™, the next release on
A minimalist illustration of a lung and a drug capsule in flat design.

Sep 9, 2026

Brainomix AI lends weight to Endeavor Bio's IPF trial data

Brainomix's AI technology has enhanced the data analysis of a phase 2a trial for Endeavor BioMedicines' taladegib, a promising treatment for idiopathic pulmonary fibrosis (IPF).The post hoc analysis revealed that taladegib (ENV-101) significantly improved lung volume and reduced both total disease extent (TDE) and fibrosis severity in patients. Specifically, those treated with taladegib experienced a notable 204 mL increase in lung volume, contrasting with a 60 mL decrease in the placebo group.
Press release cover image

Sep 5, 2026

Signant Health and Lothar Medical Sign Letter of Intent to Commercialize ALDS PRO for Clinical Trials

Collaboration creates a path to combine Signant's market-leading eCOA and digital endpoint capabilities with Lothar Medical's three-in-one ALDS PRO respiratory assessment system PHILADELPHIA, and WÜRZBURG, Germany, Sept. 5, 2026 /PRNewswire/ -- Signant Health, a leading provider of evidence generation solutions for clinical trials, and Lothar Medical today announced that they have signed a letter of intent outlining a planned strategic collaboration to bring Lothar Medical's next-generation pul
Press release cover image

Sep 4, 2026

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical D
Press release cover image

Sep 3, 2026

EClinCloud Surpasses 1,100 Clinical Trials Across 10+ Countries as Its Unified AI-Driven Platform Expands Worldwide

China-built clinical research platform now serves 300+ pharmaceutical, biotech and CRO organizations and 20,000+ users, uniting EDC, RTSM, eCOA, independent review, CTMS and eTMF with embedded AI agents on a single data model.NINGBO, China, Sept. 3, 2026 /PRNewswire/ -- EClinCloud (Ningbo) Technology Co., Ltd., developer of a unified, AI-driven clinical research platform, today announced that its technology now supports more than 1,100 clinical trials for 300+ sponsor and research organizations